Literature DB >> 12660032

Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis.

Achuthan Rajgopal1, Ian M Carr, Jack P Leek, Donald Hodge, Sandra M Bell, Paul Roberts, Kieran Horgan, David T Bonthron, Peter J Selby, Alexander F Markham, Kenneth A MacLennan.   

Abstract

The chromosomal band 1p36 exhibits frequent loss of heterozygosity in a variety of human malignancies, suggesting the presence of an as yet unidentified tumor suppressor gene. The faint terminal subbands often make cytogenetic analysis of 1p36 particularly difficult. Small deletions at this locus may therefore escape detection on analysis by conventional cytogenetics, a hypothesis that we have explored using fluorescence in situ hybridization (FISH) in malignant lymphoma. The study cohort consisted of 20 cases of lymphoma of various subtypes without any 1p abnormality on G-banded karyotyping. FISH was performed using a human chromosome 1 paint and a bacterial artificial chromosome probe RP4-755G5 localizing to 1p36.33, the most telomeric subband of 1p36. Tumors demonstrating 1p36.33 deletions were additionally analyzed by FISH using a second probe from the proximal 1p36.1 subband, to further define the breakpoint. Eight cases of follicular lymphoma (FL), 5 diffuse large B-cell lymphomas (DLBCL), 2 Hodgkin disease, 2 B-cell small lymphocytic lymphomas, 2 T-cell lymphomas, and 1 marginal zone lymphoma were analyzed. FISH identified deletions at 1p36.33 in 5 of the 20 cases: 3 DLBCL and 2 FL. FISH is considerably more sensitive for identifying lymphoma genetic alterations than conventional cytogenetics. Deletion of the distal part of the 1p36 may be a much more common aberration than previously recognized in lymphoma.

Entities:  

Mesh:

Year:  2003        PMID: 12660032     DOI: 10.1016/s0165-4608(02)00740-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

Review 1.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

2.  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.

Authors:  Robert J Clifford; Jinghui Zhang; Daoud M Meerzaman; Myung-Soo Lyu; Ying Hu; Constance M Cultraro; Richard P Finney; Jenny M Kelley; Sol Efroni; Sharon I Greenblum; Cu V Nguyen; William L Rowe; Sweta Sharma; Gang Wu; Chunhua Yan; Hongen Zhang; Young-Hwa Chung; Jeong A Kim; Neung Hwa Park; Il Han Song; Kenneth H Buetow
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

3.  Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Authors:  Francois P Duhoux; Geneviève Ameye; Virginie Lambot; Christian Herens; Frédéric Lambert; Sophie Raynaud; Iwona Wlodarska; Lucienne Michaux; Catherine Roche-Lestienne; Elise Labis; Sylvie Taviaux; Elise Chapiro; Florence Nguyen-Khac; Florence Nguyen Khac; Stéphanie Struski; Sophie Dobbelstein; Nicole Dastugue; Eric Lippert; Frank Speleman; Nadine Van Roy; An De Weer; Katrina Rack; Pascaline Talmant; Steven Richebourg; Francine Mugneret; Isabelle Tigaud; Marie-Joëlle Mozziconacci; Sophy Laibe; Nathalie Nadal; Christine Terré; Jeanne-Marie Libouton; Anabelle Decottignies; Miikka Vikkula; Hélène A Poirel
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.